Vanguard Group’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
1,298,251
-211,185
| -14% | -$230K | ﹤0.01% | 3646 |
|
|
2025
Q1 | $1.47M | Buy |
1,509,436
+88,467
| +6% | +$86K | ﹤0.01% | 3593 |
|
|
2024
Q4 | $2.1M | Buy |
1,420,969
+5,439
| +0.4% | +$8.05K | ﹤0.01% | 3548 |
|
|
2024
Q3 | $3M | Buy |
1,415,530
+91,749
| +7% | +$195K | ﹤0.01% | 3441 |
|
|
2024
Q2 | $3.23M | Buy |
1,323,781
+216,434
| +20% | +$528K | ﹤0.01% | 3413 |
|
|
2024
Q1 | $7.18M | Buy |
1,107,347
+233,909
| +27% | +$1.52M | ﹤0.01% | 3138 |
|
|
2023
Q4 | $3.37M | Buy |
873,438
+325,787
| +59% | +$1.26M | ﹤0.01% | 3426 |
|
|
2023
Q3 | $1.17M | Buy |
547,651
+83,737
| +18% | +$179K | ﹤0.01% | 3773 |
|
|
2023
Q2 | $1.41M | Hold |
463,914
| – | – | ﹤0.01% | 3786 |
|
|
2023
Q1 | $1.21M | Buy |
463,914
+14,987
| +3% | +$39K | ﹤0.01% | 3859 |
|
|
2022
Q4 | $920K | Buy |
448,927
+13,671
| +3% | +$28K | ﹤0.01% | 3935 |
|
|
2022
Q3 | $1.96M | Buy |
435,256
+39,187
| +10% | +$177K | ﹤0.01% | 3750 |
|
|
2022
Q2 | $1.62M | Sell |
396,069
-126,018
| -24% | -$515K | ﹤0.01% | 3900 |
|
|
2022
Q1 | $2.3M | Sell |
522,087
-5,458
| -1% | -$24K | ﹤0.01% | 3901 |
|
|
2021
Q4 | $6.28M | Buy |
527,545
+357,280
| +210% | +$4.26M | ﹤0.01% | 3488 |
|
|
2021
Q3 | $2.92M | Sell |
170,265
-2,862
| -2% | -$49.1K | ﹤0.01% | 3926 |
|
|
2021
Q2 | $3.02M | Buy |
+173,127
| New | +$3.02M | ﹤0.01% | 3834 |
|